Gastro-oesophageal Reflux Disease Trial, Recruiting (NCT06621706)

Gastro-oesophageal Reflux Disease Trial, Recruiting NCT06621706 Sponsor: Beni-Suef University Condition: Gastro-oesophageal Reflux Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06621706 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Gord

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Women who are pregnant and scheduled for a planned (non-emergency) caesarean section
Between 18 and 40 years of age
Classified as having a moderate level of health risk for surgery (a medical rating system called ASA class II or III — confirm with trial site if unsure what this means)
At least 37 weeks pregnant
Having a body mass index (a measure of body weight relative to height) below 35

Who may not be able to join:

People who do not wish to give their consent to participate
People whose caesarean section is performed as an emergency rather than a planned procedure
Pregnant people with conditions or diseases affecting the upper digestive system (such as the stomach or oesophagus)
People who have been taking medications that affect how the digestive system moves (for example, opioid pain medicines), or who have serious problems with major organs
People with pre-existing neurological conditions, intellectual disabilities, or physical structural differences in the body relevant to the procedure

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dina M Fakhry, MD, Beni-Suef University

Phone: +201289998680

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06621706

Sponsor: Beni-Suef University

Phase: Not Applicable

Status: Recruiting

Condition: Gastro-oesophageal Reflux Disease

Trial contact: +201289998680

More information: https://clinicaltrials.gov/study/NCT06621706

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Women who are pregnant and scheduled for a planned (non-emergency) caesarean section
Between 18 and 40 years of age
Classified as having a moderate level of health risk for surgery (a medical rating system called ASA class II or III — confirm with trial site if unsure what this means)
At least 37 weeks pregnant
Having a body mass index (a measure of body weight relative to height) below 35

Who may not be able to join:

People who do not wish to give their consent to participate
People whose caesarean section is performed as an emergency rather than a planned procedure
Pregnant people with conditions or diseases affecting the upper digestive system (such as the stomach or oesophagus)
People who have been taking medications that affect how the digestive system moves (for example, opioid pain medicines), or who have serious problems with major organs
People with pre-existing neurological conditions, intellectual disabilities, or physical structural differences in the body relevant to the procedure

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Beni-Suef University

Registry

ClinicalTrials.gov

Start date

25 September 2024

Est. completion

25 September 2025

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

mean antral cross-sectional area of stomach

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov